Executive dysfunction …

Victor W Mark MD

Neurobehavioral & Cognitive Disorders

Updated 08.02.2025
Released 08.06.2001
Expires For CME 08.02.2028

Executive dysfunction

Author: Victor W Mark MD

See Contributor Disclosures

Cite this article

Executive dysfunction

In This Article

Quick Link

Introduction

Overview

The term "executive function" broadly refers to the voluntary regulation of subsidiary cognitive functions that aim for personally relevant goals for survival, social activities, and general quality of life, including memory, language, and skillful movements. Executive function includes maintaining the level of arousal needed for specific tasks, filtering attention, goal-directed behavior, scheduling and prioritizing planned actions, anticipation of the consequences of one's actions, and mental flexibility. The analysis of executive function represents one of the most important research areas in contemporary neuroscience owing to its necessity for living independently. Historically, executive function has been associated with frontal lobe activity, though subsequent research has indicated that other brain regions also participate. Executive disorders have been documented in a diversity of conditions. Executive deficits early in dementia predict other behavioral disturbances, functional decline, and mortality. In elders, intellectual tasks and everyday activity programs may support the maintenance of executive function.

Key points

	• Executive functions govern subsidiary cognitive operations, which include problem solving, planning, inhibiting responses, strategy development and implementation, cognitive control, and working memory. Executive functions regulate other cognitions, including language, memory, perception, emotion, and action execution.
	• Three major neuroanatomical variants of executive dysfunction syndrome in reference to the frontal lobe can be distinguished: orbitofrontal, medial, and dorsolateral.
	• Executive dysfunction follows in diverse conditions, including dementia, traumatic brain injury, nonspecific cerebral white matter lesions, borderline personality disorder, substance abuse, multiple system atrophy, multiple sclerosis, schizophrenia, autism, attention deficit hyperactivity disorder, progressive supranuclear palsy, CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), and Korsakoff syndrome. It also normally appears in early childhood development and generally healthy aging.
	• The advent of the worldwide COVID-19 pandemic in 2020 was accompanied by a large number of chronic neurologic disturbances. Among them is executive dysfunction, associated with the common complaint of "brain fog” (impaired focusing of attention). The widespread executive dysfunction that follows COVID illness portends a considerable imposition on public health care resources.

Historical note and terminology

In early research on executive function, based on clinical lesion studies, the frontal lobes were observed to be selectively involved in the self-regulation of voluntary activities, such as problem solving, planning, inhibiting responses, strategy development and implementation, and working memory. Oppenheim, in the 1890s, associated personality changes with the orbital and medial frontal lobes (144; 145). Luria distinguished three primary functional units in the brain: (1) arousal-motivation (limbic and reticular systems); (2) receiving, processing, and storing information (postrolandic cortical areas); and (3) programming, controlling, and verifying activity (frontal lobes) (120). Luria regarded this third unit as having an executive role, ie, leadership for other cerebral functions. "Executive function" as a term has been addressed by many but was coalesced by Lezak to distinguish other cognitions from the "how" or "whether" of human behaviors (111). Lezak emphasized the fluidity of executive function and how the other cognitions and emotion depended on the hypothetical "executive." Baddeley grouped these behaviors into cognitive domains that included problems in planning, organizing behaviors, disinhibition, perseveration, reduced fluency, and initiation (11). Baddeley coined the term "dysexecutive syndrome." Each component of executive function has added to the array of cognitive processes, which include maintaining a problem-solving set for goal-directed behavior, interference control, flexibility, strategic planning, and the ability to anticipate and engage in goal-directed activity (45).

The definition of executive function encompasses actions fueled by conceptualizations, such as the ability to filter interference, engage in goal-directed behaviors, anticipate the consequences of one's actions, and the adaptive concept of mental flexibility (119; 120; 46; 73; 185).

Phineas Gage, the noted 19th century American railroad worker, became a metaphor for frontal lobe dysfunction, and the dysexecutive syndrome became synonymous with frontal lobe pathology. Harlow described Gage as a responsible foreman for a railroad company whose left frontal lobe was impaled by a tamping rod from an accidental explosion (89). Computer-generated 3-D reconstructions of a thin-slice computed tomography scan of the trajectory of the rod showed that the brain damage was limited to the left frontal lobe; furthermore, the ventricles and the vital intracranial vascular structures were not affected (159). It was of interest to Harlow that other cognitive functions (ie, memory, language, and sensory motor functions) remained intact, whereas personality was so greatly altered. In this instructional historical case, the “central executive” that regulates other neurologic functions was disrupted but not the basic other, foregoing neurologic functions.

During the late 19th and early 20th centuries, clinical investigations documented diverse behavioral disorders in frontal disease. In 1880, Herman Oppenheim coined the term Witzelsucht, which was demonstrated by childishness and joking with "alleged" cheerfulness (144; 145). The term moria (reflecting "stupidity" and jocular attitude) was part of the change they observed. Oppenheim’s patients all had tumors involving right frontal areas, frequently invading the mesial and basal areas. Jastrowitz noted unconcern and "inappropriate cheerfulness" (100). "Frontal lobe syndrome" was conceptualized by Feuchtwanger (61). He correlated frontal pathology with behaviors that were not related to overt speech, memory, or sensorimotor deficits. He emphasized the personality changes in motivation, affective dysregulation, and the capacity to regulate and integrate other behaviors. Kurt Goldstein expanded the capacity of frontal lobe behaviors to include "the abstract attitude," initiation, mental flexibility, and gaining both the components and the gestalt of the complex environmental arena (77). Goldstein was also sensitive to the compensatory reactions of brain injured individuals coupled with premorbid personality characteristics.

Initially, it was not apparent that "frontal lobe" and "prefrontal cortex" were not synonymous with loci associated with executive dysfunction. The first three decades of the 20th century described precisely the structure of the prefrontal regions. Vincent was one of the first researchers to become aware that the connections to the prefrontal cortex were important to function (201). Early studies elucidated hypothalamic prefrontal connections (202), thus, beginning the research into autonomic and emotional responses of the mesial-orbital prefrontal cortex. It was here that bilateral mesial prefrontal damage that involved the supplementary motor area and the singular cortex was found to produce amotivational akinetic apraxia and motor planning deficits.

When World War II yielded focal brain deficits, frontal lobe pathology was extensively evaluated. Luria related prefrontal lobe activity with programming movement, inhibiting immediate responses as needed, abstracting, problem solving, verbal regulation of behavior, reorienting behavior according to the behavioral consequences, temporal integration of behavior, personality integrity, and consciousness (119; 120).

Currently, executive function research uses functional brain imaging techniques to pool collateral findings, look at antecedents, and use a large sample size to eliminate spurious variables; thus, brain regions that contribute to dysexecutive syndromes may prove to be more multifunctional (117). Functional imaging has demonstrated that adults and children with focal, especially frontal, right-hemispheric lesions display similar behaviors such as attentional deficits, inability to inhibit a response, and impersistence of activity (62).

The relationship between executive functions and so-called general intelligence is not well-defined yet (66). Barbey and colleagues evaluated impairments on the Wechsler Adult Intelligence Scale and Delis-Kaplan Executive Function System in 182 patients with focal brain damage in relation to voxel-based lesion-symptom mapping (14). Abnormal performance in these tests was observed following damage to a distributed network of left lateralized brain areas (frontal and parietal cortex and white matter association tracts). It has also been pointed out that some executive function tests, such as the Wisconsin Card Sorting Test and Verbal Fluency, are closely linked to fluid intelligence. Departing from the hypothesis that fluid intelligence is related to executive function, a confirmatory factor analysis on a mixed neuropsychiatric and nonclinical sample found a high correlation between fluid intelligence and executive functioning (0.91), with working memory being the most profound indicator (198). A moderate to high correlation between crystallized intelligence and executive function was also present. The authors concluded that this study clearly supported the strong association between executive function and intelligence, particularly fluid intelligence. Executive dysfunction observed in some clinical conditions such as Parkinson disease can be interpreted to reflect a decrease in fluid intelligence (161).

Clinical manifestations

Presentation and course

The brain's chief executive, largely situated in the frontal lobes, orchestrates what is most distinctly human. Executive function disrupts social behaviors, motivation, and concepts that originally were guided and reinforced by external events and contingencies. The frontal lobes clearly moderate personality and affect and contribute to all behaviors. Barkley asserts that executive function primes the individual for survival by allowing appropriate self-representations to regulate internal behaviors and, thus, fosters social integration and species survival (15). The prefrontal cortex has also been identified as the core site for integrating mood and cognition (136). Goal-directed tasks and effort-demanding activities are frequently impaired in frontal lobe disease. Although language phonology, lexicon, and grammar are frequently spared, the ability to correctly select and use language (ie, language pragmatics) is significantly decreased (motor transcortical aphasia or extrasylvian aphasias). Similarly, complex aspects of writing, such as planning, narrative coherence, and maintained attention are also disturbed (dysexecutive agraphia) (10).

Stuss and Levine point out that the frontal lobes, in particular the frontal poles, are involved in uniquely human capacities that include self-awareness and mental time travel (186), although research suggests that highly intelligent other organisms may be able to conceive themselves as unique individuals, as for example with self-recognition before a mirror (175). Clinical and experimental research has converged to indicate the fractionation of frontal subprocesses and the initial mapping of these subprocesses to discrete frontal regions (186). Factor analysis has also suggested that executive functions include several subcomponents (184; 124). For example, Testa and colleagues performed a factor analysis of 19 executive function tests administered to a nonclinical sample of 200 adults, and found six independent factors: prospective working memory, set-shifting and interference management, task analysis, response inhibition, strategy generation and regulation, and self-monitoring and set-maintenance (192).

Ontogenetically, of various brain regions the frontal lobes are the last to myelinate (85). Laterally, they are anterior to the Rolandic fissure and superior to the Sylvian fissure. Medially, they extend forward from the Rolandic fissure and the corpus callosum. It is the prefrontal cortex (Brodmann areas 8, 11, 12, 24, 25, 32, 33, 46, and 47) that is thought to play a large role in neurobehavioral syndromes (120; 185). Several variants can be distinguished.

Orbitofrontal syndrome. Orbitofrontal syndrome has been associated with disinhibition, inappropriate behaviors, irritability, mood lability, tactlessness, distractibility, and loss of import to events. Affect may become extreme with moria (an excited affect) or Witzelsucht (the verbal reiteration of caustic or facetious remarks), first noted by Oppenheim (144; 145). They are unable to respond to social cues, and they are stimulus bound. Cummings noted that automatic imitation of the gestures of others may occur with large lesions (41). It was noted by Laiacona and colleagues that these patients had no difficulty with card-sorting tasks (108). Lesions of the orbitofrontal circuit may also be implicated in obsessive compulsive disorder (190; 168).

Eslinger and Damasio coined the term "acquired sociopathy" to describe dysregulation that couples both a lack of insight and remorse regarding these behaviors (56). Much of this may reflect the stimulus-bound nature of this disorder. The orbitofrontal cortex appears to be linked predominantly with limbic and basal forebrain sites. The orbital prefrontal cortex may have the ability to maintain its own level of functional arousal due to its cholinergic innervation from the basal forebrain (133).

Medial frontal lobe. The anterior cingulate is the origin of the anterior cingulate-subcortical circuit. Goldman-Rakic and Porrino identified input from Brodmann area 24 to the ventral striatum, which includes the ventromedial caudate, ventral putamen, nucleus accumbens, and olfactory tubercle (76). Damage to these circuits causes apathy or abulia (a severe form of apathy). Acute bilateral lesions in the medial frontal area can cause akinetic mutism, in which the individual is awake and has self-awareness but does not initiate behaviors (164). These patients demonstrate diminished drive. The spectrum can range to the extreme following bilateral lesions (ie, they can result in patients who can be profoundly apathetic, rarely move, may be incontinent, may eat when fed, and may speak only in monosyllables when questioned). They are not emotionally reactive, even with painful stimuli, and appear completely indifferent (42). Subcortical deficits, as seen with Parkinson disease and Huntington disease as well as thalamic lesions, may cause apathy if the anterior cingulate is affected (151; 07; 16).

Dorsolateral syndrome. Cummings indicated that the dorsolateral circuit is the most important to executive function (41). The most noted deficit is an inability to organize a behavioral response to novel or complex stimuli. Symptoms are on a continuum and reflect capacity to shift cognitive sets, engage existing strategies, and organize information to meet changing environmental demands. Dorsolateral prefrontal cortex seemingly plays a central role in global aspects of general intelligence (13). Subcortical dementias are characterized by executive dysfunction. Typically, these patients exhibit long response latencies and difficulty with semantic retrieval with preservation of recognition (29). Various researchers, including Luria, have noted preservation, stimulus-bound behavior, echopraxia, and echolalia (119). Lateralization has been noted in executive dysfunction. Following lesion to the right dorsolateral area, a transcortical motor aprosodia is expected, whereas a left-sided dorsal lesion will produce a decline in verbal fluency on word-generation tasks and extrasylvian (transcortical) motor aphasia (19). Luria noted that such patients have emotional blunting when there is bilateral involvement as well as particular difficulty with ordering and sequencing tasks and amotivation (120). Ventral and dorsal aspects of prefrontal cortex are believed to interact in the maintenance of rational and “nonrisky” decision making (123); hence, this cortical area is seemingly involved in the cognitive control of experienced decision costs (129).

Lateralization. Goldberg describes two types of cognitive control: one guiding behavior by internal cues and the other by external cues (73). Normally operating in concert, damage to the frontal lobes can result in perseveration (disinhibited repetition) due to diminished ability to switch behaviors in response to changing demands and environmental dependency as well as due to inability to generate behaviors that are guided and personal. The left prefrontal system is thought to subserve the guiding of cognitive selection by working memory and internal contingencies, whereas the right prefrontal area mediates guiding cognitive selection by external environmental contingencies.

Ardila suggested that the prefrontal lobe participates in two closely related but different executive function abilities: (1) "metacognitive executive functions" such as problem solving, planning, concept formation, strategy development and implementation, controlling attention, manipulating concepts in working memory, and the like; and (2) "emotional/motivational executive functions" such as coordinating cognition and emotion/motivation (that is, fulfilling biological needs according to some existing conditions) (08). “Metacognitive” and “emotional/motivational” executive functions may have arisen at different times during human evolution, and although primates and hominids may possess (or have possessed) the second, the first is observed only in humans and is, therefore, likely a recent evolutionary development.

Nonetheless, not all executive processes are exclusively sustained by the frontal cortex (193), even though executive dysfunction that follows focal brain injury most often occurs (or is most severe) following frontal lobe injury. Lesions in nearly any part of the brain have been associated with executive dysfunction. Contemporary research even finds strategy operations in the occipital cortical neurons on visual tasks (189). Andres analyzed two executive processes: inhibition and dual-task management (06). He concluded that (1) executive processes involve links between different brain areas, not exclusively with the frontal cortex, (2) patients with no evidence of frontal damage may present with executive deficits, and (3) patients with frontal lesions do not always show executive deficits. Using a multivariate twin study of three components of executive functions (inhibiting responses, updating working memory, and shifting between tasks), Friedman and colleagues found that executive functions are highly correlated, suggesting a common factor that goes beyond general intelligence; these authors concluded that executive functions represent one of the most heritable psychological traits (64). In a convergent study, the structural integrity on brain MRI of a major white matter bundle, the superior longitudinal fasciculus, which links the frontal and parietal cortices, better correlated with concurrent executive function in stroke patients than did either general clinical stroke severity or lesion extent (200).

Individual differences in neural mechanisms of executive control have been suggested (23). Breukelaar and colleagues investigated grey matter volume changes in children and young adults, including dorsal regions of the lateral prefrontal cortex and the parietal cortices, and they were under the assumption that these areas involve the cognitive control network (24). Volume decreases in the cognitive control network were associated with improved performance in executive function tasks in left lateral prefrontal cortex and bilateral parietal cortex. These authors suggested that these findings imply age-independent synaptic pruning in the cognitive control network may have a role in improving performance in cognitive domains.

Prognosis and complications

The severity of executive dysfunction and the pattern of recovery are variable. Recovery can be related to the extent and the etiology of the damage or advanced age. In children, executive disorders may be observed several years after the brain pathology; initial evaluation may not demonstrate dysfunction.

Clinical vignette

The patient, a 43-year-old man, had a large bifrontal meningioma resected. He did not have any overt cognitive dysfunction but was having severe headaches and personality changes, which included perseverative thinking and cognitive rigidity and inflexibility. Postsurgery, he remitted in all of these symptoms. He married several years later and, again, personality changes were noted. They were insidious but escalated. He was described by family members as having difficulty shifting from a topic and becoming obsessed with topics, ideas, and activities. It was difficult for him to shift from a given topic. He was having frequent altercations with his wife that she perceived as threatening, which led to a marital separation.

Ten years after the tumor’s resection, MRI demonstrated a recurring bifrontal meningioma in the left frontal area above the orbital roof and the lateral aspect of the frontal region. At 3 months after repeated surgery, he did not demonstrate significant deficits of memory or cognition as measured by the Wechsler Adult Intelligence Scale, or the Wechsler Memory Scale. His ability to use acquired knowledge, verbal reasoning, and comprehension of verbal information was in the high average range. Interestingly, he was in the superior range on the attentional task of digit span and letter-number sequencing, which reflected his auditory processing sequential ability, and his ability to hold memory in sensory memory for further manipulation was also in the superior range. Yet, tasks that reflected executive functions were decreased by slow processing speed and difficulty attaining novel strategies. On the category test, which measures problem solving ability, his ability to a generate hypothesis without a time frame was extremely slow. He had difficulty making constructive use of feedback initially but began to demonstrate the use of strategies to deal with novel tasks. Consistent with his performance on the Wisconsin Card Sorting Test, a task intended to identify abstract categories and the shifting of cognitive sets, he demonstrated perseverative responses that placed him in the low average range. He had difficulty relinquishing an old category but no difficulty maintaining a set. He again improved in his performance on this task as well; however, he would get up during the task and pace about the room, verbally mediating his performance. On the Stroop Test, which has a time restraint to measure the shifting of cognitive sets to conform to changing demands, he was in the impaired range, reading 67 words in 2 minutes. He demonstrated selective slowing on the conflict condition of this task. His perseveration and difficulty adopting novel strategies may reflect dorsolateral prefrontal disruption. His ability to regroup implies that various subsystems of the frontal lobe circuitry may allow for mediation and integration of tasks that are moderated by the frontal lobes.

Biological basis

Etiology and pathogenesis

	• Executive dysfunction is most often recognized following a stroke, tumor, or brain trauma.
	• Children have little capacity for mature executive function before adolescence.

Maturation changes implicate areas of prefrontal cortex that involve areas of response inhibition, maintenance of mental representations of information (working memory), and temporal organizational capacity (35). Attention deficit hyperactivity disorder is a much researched area where core deficits include impulsivity, hyperactivity, and attentional deficits (15; 109). The disorder has been interpreted as one of executive dysfunction that includes both cognitive and motor components (53; 65; 169). Executive dysfunction in attention deficit hyperactivity disorder is found at least through the late teen years both in boys and girls (174). It has also been pointed out that adolescents with conduct problems have impairments of executive function and inhibition, and that these impairments are associated with frontal dysfunction (105). Executive dysfunction may be prevalent even in younger adults. A survey of 516 community-living adults between the ages of 50 and 65, and who did not complain of cognitive difficulty, had impairment on the Clock Drawing Test (27.7%) and the Frontal Assessment Battery (14.7%) (172). At the other end of the lifespan, about 25% of hospitalized elderly rehabilitation patients have been shown to have executive dysfunction (103).

Clinically significant focal frontal lobe dysfunction is associated with aggressive dyscontrol. Violent criminals present worse response inhibition compared to nonviolent offenders; this observation suggests a more significant prefrontal abnormality in violent individuals than in nonviolent offenders (194; 132). By the same token, sexual offenders report high rates of executive dysfunction (28).

Cognitive deficits in schizophrenia parallel deficits related to executive function. Following Lezak's model, the cardinal features of executive function, which include metacognition (112)—the ability to organize and direct attention in memory to goal-directed tasks—are impaired in schizophrenia (72). It has also been suggested that executive dysfunction may be locked in at an earlier stage of schizophrenia than the cognitive deficits so often associated with the illness (171). It has been further proposed that pathology of the dorsolateral prefrontal cortices could be the neural basis of dysexecutive behaviors in schizophrenia patients (104). Analogous executive dysfunction deficits have been noted in autistic individuals who are high functioning but perseverate on tasks with difficulty disengaging from the immediate contexts (97). Executive function disorders have also been reported in other psychopathological conditions. For example, Blair and colleagues found that individuals with psychopathy showed significant impairments on those neuropsychological tests sensitive to orbitofrontal cortex function (20), and Ross and associates reported a significant correlation between psychopathy and components of executive dysfunction (165). Executive defects have been found in violent criminals (87) and serial killers (09).

Subcortical stroke and vascular dementias demonstrate executive dysfunctions (107; 139), and subcortical lacunes are associated with executive dysfunction in otherwise cognitively normal elderly people (33). The vascular dementias are often implicated in executive dysfunction such as progressive subcortical vascular encephalopathy and selective incomplete white matter infarction. Executive dysfunction significantly predicts future decline in this dementia (22). Diseases that are subcortical and also affect executive function are Huntington disease, Parkinson disease, progressive supranuclear palsy, multiple sclerosis, HIV, subcortical vascular dementia, and Wilson disease (55; 99; 125; 51). The executive deficits noted in these subcortical disorders may reflect a lack of facilitation of frontal integrity during executive tasks. It has been suggested that the various cognitive symptoms found in Parkinson disease are secondary to executive dysfunction (94) and probably due to impairments in frontostriatal circuits (212; 50). With PET, patients with Parkinson disease have reduced activation of the dorsolateral, frontal, mesial frontal, and striatal areas during cognitive tasks (07). Apathy, a cardinal feature in subcortical disorders, presents with poor self-initiation. Motivation and capacity can be present (55); thus, apathy may not reflect mood congruence. Executive dysfunction has also been reported in a case of anterior thalamic ischemia (116). Of note, ApoEe4 allele carrier status has been found to be significantly associated with executive dysfunction in Parkinson disease (167).

Stroke represents a frequent etiology of executive dysfunction, although specific manifestations can be different in different individuals. In a review, the incidence of executive dysfunction has been reported to range between 25% to 75% (178). Executive dysfunction has been documented in a diversity of conditions, including small vessel disease (138), traumatic brain injury (even in children) (71; 63; 90; 40; 70), Parkinson disease (31), white matter lesions (197), moyamoya disease (30; 58), myotonic dystrophy type 2 (155), borderline personality disorder (49; 86), substance abuse (17; 93; 60; 121; 179), multiple system atrophy (27), multiple sclerosis (170; 36), autism (95; 67), contact-sport athletes (such as football players) (173), late life anxiety and depression (209; 160), progressive supranuclear palsy (134; 68), temporal lobe epilepsy (02), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (150), extra X chromosome (47,XXY and 47,XXX) syndrome (199), amyotrophic lateral sclerosis (48), and Korsakoff syndrome (25; 148). Patients with mild cognitive impairment also present a high prevalence of executive dysfunction symptoms (21; 163; 37). Executive functions are highly sensitive to diverse abnormal conditions, and even less effective executive function has been documented after a single night's sleep deprivation (143).

The COVID-19 (SARS-CoV-2) worldwide viral pandemic that began in 2020 has been accompanied by diverse chronic symptoms, despite recovery from the contagious phase of the illness. About 57% of persons may have such “long COVID” illness (191). The illness is associated with new-onset global cortical atrophy (52). This finding implies a serious, widespread neurologic disorder whose long-term effects are not yet understood. Furthermore, many instances of acute executive dysfunction have been reported to follow COVID illness (92; 158; 18; 79; 83; 91; 101; 147; 98; 52), which commonly co-occurs with the complaint of “brain fog” or impairment with focusing attention.

Aging can affect one's ability to recall temporal ordering of events in both healthy and demented individuals. It is important to differentiate normal aging decrement from frontal dementia. This evaluation includes executive function. Gunning-Dixon and Raz examined the neuroanatomical substrates of age-related differences in working memory and perseverative behavior in a sample of healthy adults (50 to 81 years old) (84). Regional brain volumes and the volume of white matter hyperintensities were measured on magnetic resonance images. The analyses indicated that the volume of the prefrontal cortex and the volume of white matter hyperintensities in the prefrontal region are independently associated with age-related increases in perseverative errors on the Wisconsin Card Sorting Test.

So-called mild cognitive impairment is characterized as a transitional state when decreased performance on selected cognitive domains is observed (156; 113), frequently predicting a dementia. Different subtypes of mild cognitive impairment have been distinguished, including a dysexecutive mild cognitive impairment subtype characterized by relatively specific deficits in executive functions. Huey and colleagues selected 1167 ethnically diverse elders with clinical and cognitive testing for an average of 4.5 years (SD = 0.8 year). Four different subgroups of patients with mild cognitive impairment were separated: single-domain amnestic and dysexecutive mild cognitive impairment, and multiple-domain mild cognitive impairment with and without executive dysfunction. It was found that dysexecutive mild cognitive impairment was less associated with Alzheimer disease and more associated with stroke than amnestic mild cognitive impairment (96).

Small vessel disease, Binswanger disease, and frontotemporal dementia have a particular affinity for the prefrontal circuitry. Frontotemporal dementia is characterized by atrophy of the frontotemporal cortices, microvacuolation, gliosis, and synaptic and neuronal loss with the presence of Pick bodies (180). Alzheimer disease, primarily a neurodegeneration of the cortex, begins in limbic and hippocampal structures and spares (as a rule) the sensory and motor cortex. In later stages, the prefrontal and frontal cortices become involved; however, executive dysfunction may be an early feature of some patients with Alzheimer disease (130). The structural correlate to certain dimensions of executive dysfunction in patients with Alzheimer disease has been suggested to relate to changes in the deep frontal white matter (177). In patients with both Alzheimer disease and mild cognitive impairment a significant association between hippocampal atrophy and executive dysfunction has been demonstrated (142).

When comparing the neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease, both the patients with Alzheimer disease and semantic dementia are significantly impaired relative to the frontotemporal dementia group on verbal memory, whereas only the Alzheimer disease group is impaired on visual memory. Patients with frontotemporal dementia perform significantly worse on backward digit span and make significantly more executive errors than Alzheimer disease and semantic dementia patients. Patients with semantic dementia are more impaired than patients with Alzheimer disease and frontotemporal dementia on confrontation naming (106). It has been reported that performance on executive function tests presents an accelerated decline 2 to 3 years before the diagnosis of Alzheimer disease (82). By the same token, executive defects early in the dementia process represent a predictor of subsequent behavior disturbances (196), further functional decline, and mortality (102). A consistent association between activities of daily living in Alzheimer disease and executive functions has been reported (126), and a behavioral or dysexecutive variant of Alzheimer disease has been reported (149).

Graham and colleagues analyzed the distinctive cognitive profiles in Alzheimer disease and subcortical vascular dementia (80). They concluded that both patient groups have impairments in all cognitive domains. The Alzheimer patients, however, are more impaired than those with vascular dementia on episodic memory, whereas the patients with vascular dementia were more impaired on semantic memory, executive and attentional function, general attention, and visuospatial and perceptual skills. Interestingly, it has been documented that executive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia (69).

The disruptions that occur are both structural and chemical. Disruption of these cortical-subcortical circuits interrupts functions of the intact brain. Lesions of the dorsolateral circuit are associated with metacognition deficits, lesions of the orbitofrontal-subcortical circuit are associated with disinhibition, and lesions of the anterior cingulate circuit are associated with apathy and abulia. Each circuit is modulated by both an indirect and direct pathway to the thalamus. The direct effect of the circuit is to disinhibit the thalamus; the indirect pathway inhibits the thalamus. The indirect pathway includes the subthalamic nucleus. Although each circuit shares anatomical open afferent and efferent connections to allow communication between the circuits, neurotransmitter functions vary (38). The neurochemistry of frontal lobe integrity is core circuits that form functional neural loops to connect frontal to cortical regions. These loops reverberate from the basal ganglia, thalamus, and back to the frontal cortex. The core neurotransmitters are glutamate, an excitatory neurotransmitter, and gamma-aminobutyric acid, the major inhibitory neurotransmitter in the brain (59).

Alexander and colleagues described cumulative firings that will inhibit or disinhibit activity of the frontal-subcortical loop (04). These parallel systems allow mediation of subcircuits to selectively modulated signals that pass through the basal ganglia to the frontal cortex (59). Parent and colleagues also identified acetylcholine as contributing to frontal-subcortical signaling in the striatum (153). It is thought to play a role in more than half of the muscarinic receptors of the dorsolateral prefrontal cortex. Cholinomimetic drugs facilitate glutamate transmission in corticocortical and corticostriatal pathways. Dopamine appears to play a role in reciprocal regulation of frontal subcortical pathways.

Saxena and colleagues review structural and functional neuroimaging research that indicates hyperactivity in orbitofrontal-subcortical circuits, which may involve dysregulation in striatopallidal pathways (168). The involvement of orbitofrontal-subcortical pathways on functional imaging reinforces the comment by Mega and Cummings that frontal-subcortical circuits form one of the principal organizational networks of the brain and are central to brain-behavior relationships (131). Noteworthy, it has been observed that the prefrontal cortex white matter is particularly sensitive to aging.

Subcortical dysregulation of frontal systems reflects the direct connections between the frontal and striatal circuits. It is thought that subcortical difficulties can be secondary to executive function impairment. Cognitive studies using neuropsychological measures have implicated executive dysfunction in Parkinson disease, which, in turn, can predict progression to dementia years later (210). PET studies confirm reduced activation of dorsolateral frontal, mesial frontal, and striatal regions in patients with Parkinson disease during cognitive tasks (07).

Differential diagnosis

Confusing conditions

Impaired arousal can be confused with impaired action initiation, an aspect of executive function. When initiation (or spontaneous voluntary activity) is selectively impaired, other cognitive functions may be intact, for example, reciting well-learned material only on request, such as the alphabet or the months in their normal order. In contrast, impaired arousal will similarly limit all cognitive functions, executive and other. Impaired arousal can be judged when a patient does not obey commands while appearing to be drowsy. Further detail on the select interference with spontaneous voluntary activity in neurologic disease is discussed in the article in automatic-voluntary dissociation.

Disturbance of Theory of Mind resembles executive dysfunction. Theory of Mind refers to the ability to infer the mental functions of another person without direct knowledge, for example, by watching another person’s change in gaze or facial gestures. Theory of Mind is vital to healthy social interaction and relies on abstraction, an executive function. Consequently, executive dysfunction can undermine Theory of Mind. Nonetheless, Theory of Mind operations can be dissociated from formal executive assessments (01), which suggests that Theory of Mind as a general function is distinct from executive function.

Associated or underlying disorders

Aging ordinarily involves executive deficits, including planning, alternating responses, controlling attention, and decision making. The extent of the aging effect is, however, different for various executive tasks and seems to be mediated by education (162). Lin and colleagues used seven executive function tests in two groups of healthy elders, with one group aged 60 to 70 years and the other over 70 years. A significant difference was found between the two groups in attention, planning, and total score. Regression analyses, however, indicated that age accounted for just little variance, whereas education level accounted for a large part of varying initiation, switching and flexibility, and updating components of executive function (115). Gomez-Perez and Ostrosky-Solis observed that whereas tests related to memory are sensitive to aging, those related to executive function are mostly sensitive to education (78). Etienne and colleagues, using the 3-component model of executive functions proposed by Miyake and colleagues (inhibition of irrelevant information, updating of information in working memory, and mental shifting between tasks), found that inhibition and updating were impaired in older subjects, whereas flexibility was not (137; 57).

Executive dysfunction is usually observed in dementia and is most often noted in frontotemporal dementia and traumatic brain injury. Executive dysfunction also can occur in early Alzheimer disease; the specific impairment pattern of impairment can vary (183). It has been suggested that in mild cognitive impairment, two different subgroups can be separated: amnesic and dysexecutive. In the latter one, significantly lower scores in executive function tests, increased behavioral symptoms, and left prefrontal cortex atrophy on magnetic resonance imaging are found (152). It has been reported that impaired subcortical connectivity is associated with significant network disruption in traumatic brain injury and that this disruption is related to the executive dysfunction found in these patients (47).

Depressed patients may present impairments in executive function, including problems with planning, initiating, and completing goal-directed activities (43). Some memory dysfunctions (in particular, lack of responsive to cues) are associated with executive dysfunction (154). Executive function fully develops during adolescence; in minors, an inability to successfully perform in executive function tasks is observed.

Comorbid non-neurologic diseases may affect executive control, a research area that is little explored. Glaucoma (excessive intraocular pressure associated with retinal damage) can impede visual executive test scores (110).

Diagnostic workup

It is difficult to separate intellectual function from executive function. Dysexecutive syndrome can disrupt self-regulating, stimulus control, and purposeful rational thought, thus, affecting test performance. Many of the "executive tasks" attempt to tap into the individual’s ability to formulate strategies, to separate essential from nonessential, and adapt to conditions that become novel. It has been emphasized that there is no single measure of executive function; rather, different tests represent different executive components and, as such, more than one measure should be used in a comprehensive assessment (12). Administering several tests of executive function to assess particular aspects of the executive function is recommended (74). Some standardized assessment test batteries are currently available, such as the Delis-Kaplan Executive Function System (D-KEFS) (44), the Behavioural Assessment of the Dysexecutive Syndrome (206), the Frontal Assessment Battery (54), and the Executive and Social Cognition Battery (195). The D-KEFS can predict independence in home-based self-care in the elderly (188).

Tests frequently used include the Wisconsin Card Sorting Test and the category test, which test the dual task performance and the ability to shift cognitive sets. Observing the individual engage in tasks that are ambiguous and frustrating may reflect problems associated with real-life behaviors. Perseverations and the inability to shift from one stimulus to another as well as problems of working memory with inattention and failure to maintain set may appear during these tests (118).

Other tests, such as part B of the Trail Making Test and the Stroop Color Word Test, demonstrate slowing of responses as well as difficulty with set-shifting and maintaining attention to task (vigilance). During memory tasks that demonstrate proactive interference, one may observe preservations from previous items or interference with new information on tasks. The paced auditory serial attention task involves working memory, cognitive flexibility, and attentional vigilance to task. This task requires both the ability to inhibit responses and maintain an attentional set. The ability to inhibit distractions and engage in complex processing speed is an integral component of these tasks (112). Picture arrangement, matrix reasoning, and number-letter sequencing can, at least partially, be regarded as executive function tests.

Most neuropsychological tests provide an external structure for the task. Adaptive processes include priorities and internally guiding the individual toward goals and objectives. Goldberg and Podell indicate that tasks are needed that require the subject to make selections based on his or her preferences rather than on stimulus characteristics or constraints (75). The tasks must remain ambiguous and the choice of responses left up to the subject. Reliable behavioral observations are needed in addition to formal testing (122). Currently, several questionnaires are available such as the Dysexecutive Questionnaire Revised (DEX-R) (176). Some ecological measures of executive functions have been also proposed (128; 211). A composite executive function battery (entailing the Trail Making, Digit Symbol, Letter-Number Sequencing, Semantic Fluency, and Phonemic Fluency tests) can predict cognitive progression in Parkinson disease to dementia, more so than can a brief bedside cognitive assessment (the Montreal Cognitive Assessment) (210).

The Behavioral Dyscontrol Scale (BDS) is a frequently used battery of executive function (81). It assesses working memory, motor learning, motor programming, and behavioral inhibition and requires about 10 minutes. The BDS is more sensitive for detecting frontotemporal dementia when compared to Alzheimer disease (05). This assessment also can predict the extent of recovery during inpatient rehabilitation following orthopedic injury, though not for other post-surgery populations (141).

However, there are limits to the ability of standard laboratory-based executive function tests to predict everyday activities. In a study of the failures of adolescents to manage their type 1 diabetes mellitus, a self-report of difficulties of executive function (the Behavior Rating Inventory of Executive Functioning) could predict the self-management failures, whereas the D-KEFS could not (205). In addition, a limitation toward assessing executive function in brain-diseased populations is the common complexity of instructions. Consequently, it is generally difficult to assess the executive abilities of people with impaired auditory comprehension, such as following aphasia (203).

Automated executive function assessment is becoming available. One approach is through infrared eye movement tracking during computerized testing. On one test, in which one must direct eyes opposite to a suddenly appearing stimulus, errors could be registered objectively instead of relying on observer assessment. On another test, the participant simply must not reflexively redirect gaze to an unexpected visual stimulus. Such methods may enhance diagnosing minimal cognitive impairment (146). A computerized version of the BDS has been shown to overcome limitations in subjective scoring of the test on the original version (187).

Smartphone assessment can conveniently assess executive function in the convenience of one’s home. In one such app, the ALLFTD-mApp, variants of classical executive function tests are included (Flanker, Go/No Go [tap when you see a fish as on a sushi dish, withhold tapping when seeing other than a fish], Card Sort [variant of the Wisconsin Card Sorting Test], Stroop color test variant) (182).

Management

Specific therapy for executive dysfunction is not well developed. Patients with difficulty with initiation, impulsivity, or lack of self-regulation demonstrate better response to environmental cues and external reinforcement of appropriate behaviors. Cognitive retraining can utilize compensatory devices, cues for self-instruction, and metacognitive strategies (127). The Short-Term Executive Plus (STEP) cognitive rehabilitation program has demonstrated to be useful in improving self-reported executive dysfunction in patients with traumatic head injury (32). Manipulation and modification of environmental conditions as well as behavior management have also been used in patients with executive disorders (140). Positive effects of cognitive training on the ability to set and accomplish realistic goals; to plan, initiate, and maintain real-life activities; and to resume previous social and working roles have been reported (181).

Intellectual tasks and everyday activity programs have proven beneficial in increasing executive function abilities. In a pioneer study, 149 older sedentary adults were trained to help elementary school children with reading achievement, library support, and classroom behavior for 15 hours weekly during an academic year. Participants presented some improvements in executive functions and memory when compared with matched controls. Participants with impaired baseline scores improved about 44% in executive functions and 51% in memory (34). Some authors have successfully used multidisciplinary rehabilitation programs to improve executive functions in patients with acquired brain injury and executive dysfunction (157).

Computerized training to boost the speed of decision-making on visual tasks can carry over to improving select executive function assessments (Stroop test, Trail Making Test B) in elderly individuals (207). It is not yet clear whether such training can extend to improving self-care. In a related trial, training in piano playing bested computer training on improving perception on executive test assessments in elderly participants, though retention of improvements was not examined (26).

A review has suggested that exercise can enhance executive function in the elderly (114). The elements that most improved executive function were sessions that were daily, not exceeding 45 minutes, and that used intensive training. The striking relationship between the degree of visual acuity and executive function (specifically, timed performance on the Trail Making Test B) suggests that treating impaired visual acuity could improve executive function (166). Multimodal music rehabilitation (group singing, lyric memorization, and song discussion, among other techniques) can boost executive function in persons with Parkinson disease (204), though the critical element has not yet been identified.

Noninvasive electrical brain stimulation has been an emerging treatment approach for managing executive dysfunction after traumatic brain injury. The approaches involve either transcranial magnetic stimulation or transcranial direct current stimulation, directed at the dorsolateral prefrontal cortex. Thus far, there has not been demonstrated effectiveness from these approaches (88). These forms of treatment have benefited executive functions in intellectually impaired children, but the study samples were, thus far, too small to be considered conclusive (135).

Pharmacological approaches that alter neurotransmitter function can have beneficial results. The dopamine system in the prefrontal cortex is more sensitive to mild reductions in its precursor tyramine. Selectively depleting dorsolateral prefrontal dopamine can produce deficits as severe as total ablation, and dopamine antagonists impair performance of working memory functions believed to be related to dorsolateral prefrontal involvement. Noradrenergic agonists and dopamine agonists as well as atypical antipsychotics (ie, risperidone) increase dopamine in the frontal cortex. Psychostimulants, such as methylphenidate (a sympathomimetic), stimulate norepinephrine and dopamine release. Dopamine agonists may improve activity initiation (164). Bromocriptine has been used to improve speech initiation in aphasia. Albert and colleagues attempted to restore speech fluency in a patient with long-standing transcortical motor aphasia by treating his symptoms of hesitancy and impaired initiation of speech with bromocriptine (03). During therapy, his language performance improved substantially due to reduced latency of response, decreased paraphasias, and increased naming ability. After cessation of drug therapy, his language returned to baseline. Unfortunately, treatment response to bromocriptine is highly variable.

Coull and colleagues investigated the use of alpha-2 antagonists (idazoxan) on cognition in frontal lobe dementias (39). The results supported the role of the alpha-2 adrenoreceptor in both executive function and, most likely, as an attentional modulator that may mediate executive function indirectly.

References

01: Aboulafia-Brakha T, Christe B, Martory MD, Annoni JM. Theory of mind tasks and executive functions: a systematic review of group studies in neurology. J Neuropsychol 2011;5:39-55. PMID 21366886
02: Agah E, Asgari-Rad N, Ahmadi M, Tafakhori A, Aghamollaii V. Evaluating executive function in patients with temporal lobe epilepsy using the frontal assessment battery. Epilepsy Res 2017;133:22-7. PMID 28407518
03: Albert ML, Bachman DL, Morgan A, Helm-Estabrooks N. Pharmacotherapy for aphasia. Neurology 1988;38:877-9. PMID 3368068
04: Alexander GE, Crutcher MD, Delong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, prefrontal and limbic functions. Prog Brain Res 1990;85:119-46. PMID 2094891
05: Alsemari A, Malloy PF. The Behavioral Dyscontrol Scale in the differential diagnosis of behavioral variant of frontotemporal dementia and Alzheimer disease. Clin Neuropsychol 2021;35:633-42. PMID 31842672
06: Andres P. Frontal cortex as the central executive of working memory: time to revise our view. Cortex 2003;39:871-95. PMID 14584557
07: Antonini A, Vontobel P, Psylla M, et al. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch Neurol 1995;52:1183-90. PMID 7492293
08: Ardila A. On the evolutionary origins of executive functions. Brain Cogn 2008;68:92-9. PMID 18397818
09: Ardila A, Ostrosky-Solis F. Neuropsicología de los asesinos en serie. [Spanish]. Rev Neurol 2009;48:162-3. PMID 19206066
10: Ardila A, Surloff C. Dysexecutive agraphia: a major executive dysfunction sign. Int J Neurosci 2006;116:653-63. PMID 16644524
11: Baddeley A. Working memory. Oxford: Oxford University Press, 1986.
12: Bamdad MJ, Ryan LM, Warden DL. Functional assessment of executive abilities following traumatic brain injury. Brain Inj 2003;17:1011-20. PMID 14555361
13: Barbey AK, Colom R, Grafman J. Dorsolateral prefrontal contributions to human intelligence. Neuropsychologia 2013;51:1361-9. PMID 22634247
14: Barbey AK, Colom R, Solomon J, Krueger F, Forbes C, Grafman J. An integrative architecture for general intelligence and executive function revealed by lesion mapping. Brain 2012;135:1154-64. PMID 22396393
15: Barkley RA. ADHD and the nature of self-control. New York: Guilford Press, 1997.
16: Baudic S, Maison P, Dolbeau G, et al. Cognitive impairment related to apathy in early Huntington's disease. Dement Geriatr Cogn Disord 2006;21:316-21. PMID 16484810
17: Bechara A, Martin EM. Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 2004;18:152-62. PMID 14744198
18: Becker JH, Lin JJ, Doernberg M, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open 2021;4:e2130645. PMID 34677597
19: Benton AL. Differential effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
20: Blair KS, Newman C, Mitchell DG, et al. Differentiating among prefrontal substrates in psychopathy: neuropsychological test findings. Neuropsychology 2006;20:153-65. PMID 16594776
21: Bombois S, Debette S, Delbeuck X, et al. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke 2007;38:2595-7. PMID 17656658
22: Boyle PA, Paul RH, Moser DJ, Cohen RA. Executive impairments predict functional declines in vascular dementia. Clin Neuropsychol 2004;18:75-82. PMID 15595360
23: Braver TS, Cole MW, Yarkoni T. Vive les differences! Individual variation in neural mechanisms of executive control. Curr Opin Neurobiol 2010;20:242-50. PMID 20381337
24: Breukelaar IA, Antees C, Grieve SM, et al. Cognitive control network anatomy correlates with neurocognitive behavior: a longitudinal study. Hum Brain Mapp 2017;38:631-43. PMID 27623046
25: Brokate B, Hildebrandt H, Eling P, Fichtner H, Runge K, Timm C. Frontal lobe dysfunctions in Korsakoff's syndrome and chronic alcoholism: continuity or discontinuity. Neuropsychology 2003;17:420-8. PMID 25532153
26: Bugos JA, Wang Y. Piano training enhances executive functions and psychosocial outcomes in aging: results of a randomized controlled trial. J Gerontol B Psychol Sci Soc Sci 2022;77:1625-36. PMID 35134913
27: Burk K, Daum I, Rub U. Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord 2006;21:772-6. PMID 16475154
28: Burton D, Demuynck S, Yoder JR. Executive dysfunction predicts delinquency but not characteristics of sexual aggression among adolescent sexual offenders. Sex Abuse 2016;28:707-21. PMID 25428928
29: Butters N, Wolfe J, Granholm E, Martone M. An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease. Cortex 1986;22:11-32. PMID 2940074
30: Calviere L, Ssi Yan Kai G, Catalaa I, Marlats F, Bonneville F, Larrue V. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter. J Neurol Neurosurg Psychiatry 2012;83:591-3. PMID 22378919
31: Campos-Sousa IS, Campos-Sousa RN, Ataíde Jr L, Soares MM, Almeida KJ. Executive dysfunction and motor symptoms in Parkinson's disease. Arq Neuropsiquiatr 2010;68:246-51. PMID 20464294
32: Cantor J, Ashman T, Dams-O'Connor K, et al. Evaluation of the short-term executive plus intervention for executive dysfunction after traumatic brain injury: a randomized controlled trial with minimization. Arch Phys Med Rehabil 2014;95:1-9.e3. PMID 23988395
33: Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008;39:397-402. PMID 18096844
34: Carlson MC, Saczynski JS, Rebok GW, et al. Exploring the effects of an "everyday" activity program on executive function and memory in older adults: Experience Corps. Gerontologist 2008;48:793-801. PMID 19139252
35: Casey BJ. Maturation in brain activation. Am J Psychiat 1999;156:504-8. PMID 10200727
36: Cerezo García M, Martín Plasencia P, Aladro Benito Y. Alteration profile of executive functions in multiple sclerosis. Acta Neurol Scand 2015;131:313-20. PMID 25659411
37: Chen NC, Chang CC, Lin KN, et al. Patterns of executive dysfunction in amnestic mild cognitive impairment. Int Psychogeriatr 2013;25:1181-9. PMID 23574879
38: Chow TW, Cummings JL. Frontal-subcortical circuits. In: Miller BL, Cummings JL, editors. The human frontal lobes: functions and disorders. New York: Guilford Press, 1999:3-26.
39: Coull JT, Sahakian BJ, Hodges JR. The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type. Psychopharmacology (Berl) 1996;123:239-49. PMID 8833417
40: Crowe LM, Catroppa C, Babl FE, Anderson V. Executive function outcomes of children with traumatic brain injury sustained before three years. Child Neuropsychol 2013;19:113-26. PMID 22384854
41: Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-80. PMID 8352676
42: Damasio H, Damasio AR. Lesion analysis in neuropsychology. New York: Oxford University Press, 1989.
43: DeBattista C .Executive dysfunction in major depressive disorder. Expert Rev Neurother 2005;5:79-83. PMID 15853477
44: Delis DC, Kaplan E, Kramer JK. Delis-Kaplan Executive Function System (D–KEFS). San Antonio: Harcourt Assessment, Inc, 2001.
45: Denckla MB. Measurement of executive function. In: Lyon GR, editor. Frames of reference for the assessment of learning disabilities: new views on measurement issues. Baltimore, MD: Paul H Brooks, 1994:117-42.
46: Denckla MB. A theory and model of executive function: a neuropsychological perspective. In: Lyon GR, Krasnegor NA, editors. Attention, memory and executive function. Baltimore, MD: Paul H Brooks, 1996:263-77.
47: De Simoni S, Jenkins PO, Bourke NJ, et al. Altered caudate connectivity is associated with executive dysfunction after traumatic brain injury. Brain 2018;141:148-64. PMID 29186356
48: Dimond D, Ishaque A, Chenji S, et al. White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis. Hum Brain Mapp 2017;38:1249-68. PMID 27796080
49: Dinn WM, Harris CL, Aycicegi A, Greene PB, Kirkley SM, Reilly C. Neurocognitive function in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:329-41. PMID 14751430
50: Dirnberger G, Frith CD, Jahanshahi M. Executive dysfunction in Parkinson's disease is associated with altered pallidal-frontal processing. Neuroimage 2005;25:588-99. PMID 15784438
51: Dominguez DJ, Poudel G, Stout JC, et al. Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington's disease: 30 months IMAGE-HD data. Cortex 2017;92:139-49. PMID 28482181
52: Douaud G, Lee B, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022;604(7907):697-707. PMID 35255491
53: Douglas VI. Cognitive control processes in attention deficit hyperactivity disorder. In: Quay HC, Hogan AE, editors. Handbook of disruptive disorders. New York: Plenum Press, 1999:105-38.
54: Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55:1621-6. PMID 11113214
55: Elias JW, Treland JE. Executive function in Parkinson's disease and subcortical disorders. Sem Clin Neuropsychiatry 1999;4:34-40. PMID 10229791
56: Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal ablation. Neurology 1985;35:1731-41. PMID 4069365
57: Etienne V, Marin-Lamellet C, Laurent B. Évolution du contôle exécutif au cours du vieillissement normal. [In French].Rev Neurol (Paris) 2008;164:1010-7. PMID 18808784
58: Fang L, Huang J, Zhang Q, Chan RC, Wang R, Wan W. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes. J Neurosurg 2016;125:299-307. PMID 26722860
59: Feifel D. Neurotransmitters and neuromodulators in frontal-subcortical circuits. In: Miller BL, Cummings JL, editors. The human frontal lobes. New York: The Guilford Press, 1999:174-86.
60: Fernandez-Serrano MJ, Pérez-García M, Perales JC, Verdejo-García A. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities. Eur J Pharmacol 2010;626:104-12. PMID 19836375
61: Feuchtwanger E. Die Funktionen des Stirnhirns. [In German]. Berlin: Springer, 1923.
62: Filley CM, Young DA, Reardon MS, Wilkening GN. Frontal lobe lesions and executive dysfunction in children. Neuropsychiatry Neuropsychol Behav Neurol 1999;12:156-60. PMID 10456798
63: Fork M, Bartels C, Ebert AD, Grubich C, Synowitz H, Wallesch CW. Neuropsychological sequelae of diffuse traumatic brain injury. Brain Inj 2005;19:101-8. PMID 15841754
64: Friedman NP, Miyake A, Young SE, Defries JC, Corley RP, Hewitt JK. Individual differences in executive functions are almost entirely genetic in origin. J Exp Psychol Gen 2008;137:201-25. PMID 18473654
65: Fuggetta GP. Impairment of executive functions in boys with attention deficit/hyperactivity disorder. Child Neuropsychol 2006;12:1-21. PMID 16484099
66: Garcia-Molina A, Tirapu-Ustárroz J, Luna-Lario P, Ibáñez J, Duque P. Son lo mismos inteligencia y funciones ejecutivas? [In Spanish]. Rev Neurol 2010;50:738-46. PMID 20533252
67: Garon N, Smith IM, Bryson SE. Early executive dysfunction in ASD: simple versus complex skills. Autism Res 2018;11:318-30. PMID 29149519
68: Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I; ENGENE-PSP Study Group. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol 2013;28:104-13. PMID 23127882
69: Geschwind DH, Robidoux J, Alarcon M, et al. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol 2001;50:741-6. PMID 11761471
70: Ghawami H, Sadeghi S, Raghibi M, Rahimi-Movaghar V. Executive functioning of complicated-mild to moderate traumatic brain injury patients with frontal contusions. Appl Neuropsychol Adult 2016;1-9. PMID 27101223
71: Gioia GA, Isquith PK. Ecological assessment of executive function in traumatic brain injury. Dev Neuropsychol 2004;25:135-58. PMID 14984332
72: Gold TM, Harvey PD. Cognitive deficits in schizophrenia. East Sussex, UK: Erlbaum Press, 1993.
73: Goldberg E. The executive brain. New York: Oxford University Press, 2001.
74: Goldberg E, Bougakov D. Neuropsychologic assessment of frontal lobe dysfunction. Psychiat Clin North Am 2005;28:567-80. PMID 16122567
75: Goldberg E, Podell K. Adaptive decision making, ecological validity, and the frontal lobes. J Clin Exp Neuropsychol 2000;22:56-68. PMID 10649545
76: Goldman-Rakic PS, Porrino LJ. The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985;242:535-60. PMID 2418080
77: Goldstein K. The mental changes due to frontal lobe damage. J Psychol 1944;17:187-208.
78: Gomez-Perez E, Ostrosky-Solis F. Attention and memory evaluation across the life span: heterogeneous effects of age and education. J Clin Exp Neuropsychol 2006;28:477-94. PMID 16624779
79: Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers." Ann Clin Transl Neurol 2021;8:1073-85. PMID 33755344
80: Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry 2004;75:61-71. PMID 14707310
81: Grigsby J, Kaye K, Robbins LJ. Reliabilities, norms and factor structure of the Behavioral Dyscontrol Scale. Percept Mot Skills 1992;74:883-92. PMID 1608726
82: Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008;14:266-78. PMID 18282324
83: Gulick SH, Mandel S, Maitz EA, Brigham CR. Cognitive screening after COVID-19 [review]. Pract Neurol 2021;20:19-23.
84: Gunning-Dixon FM, Raz N. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia 2003;41:1929-41. PMID 14572526
85: Gur RC. Brain maturation and its relevance to understanding criminal culpability of juveniles [review]. Curr Psychiatry Res 2005;7:292-6. PMID 16098283
86: Gvirts HZ, Harari H, Braw Y, Shefet D, Shamay-Tsoory SG, Levkovitz Y. Executive functioning among patients with borderline personality disorder (BPD) and their relatives. J Affect Disord 2012;143:261-4. PMID 22963893
87: Hancock M, Tapscott JL, Hoaken PN. Role of executive dysfunction in predicting frequency and severity of violence. Aggress Behav 2010;36:338-49. PMID 20593426
88: Hara T, Shanmugalingam A, McIntyre A, Burhan AM. The effect of noninvasive brain stimulation (NIBS) on executive functioning, attention and memory in rehabilitation patients with traumatic brain injury: a systematic review. Diagnostics 2021;11:627. PMID 33807188
89: Harlow JM. Recovery from the passage of an iron bar through the head. Massachusetts Med Soc Publ 1868;2:327-46.
90: Hartikainen KM, Waljas M, Isoviita T, et al. Persistent symptoms in mild to moderate traumatic brain injury associated with executive dysfunction. J Clin Exp Neuropsychol 2010;32:767-74. PMID 20198531
91: Hellmuth J, Barnett TA, Asken BM, et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol 2021;27:191-5. PMID 33528824
92: Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268-70. PMID 32294339
93: Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 2004;24:11017-22. PMID 15590917
94: Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA. The relationship between executive function and verbal memory in Parkinson's disease. Brain Cogn 2003;52:343-52. PMID 12907179
95: Hill EL. Executive dysfunction in autism. Trends Cogn Sci 2004;8:26-32. PMID 14697400
96: Huey ED, Manly JJ, Tang MX, et al. Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement 2013;9:632-9. PMID 23452959
97: Hughes C, Russell J, Robbins TW. Evidence for executive dysfunction in autism. Neuropsychology 1994;32:477-92. PMID 8047253
98: Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol 2022;269:44-6. PMID 34143277
99: Jahanshahi M, Rowe J, Saleem T, et al. Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and after unilateral posteroventral pallidotomy. J Cogn Neurosci 2002;14:298-310. PMID 11970793
100: Jastrowitz M. Beiträge zur Localisation im Grosshirn and über deren prakitsche Verwerthung. [In German]. Verwerthma. Dtsch Med Wochenschr 1888;14:81-3.
101: Jaywant A, Vanderlind WM, Alexopoulos GSF, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology 2021;46:2235-40. PMID 33589778
102: Johnson JK, Lui LY, Yaffe K. Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci 2007;62:1134-41. PMID 17921427
103: Kahokehr A, Siegert RJ, Weatherall M. The frequency of executive cognitive impairment in elderly rehabilitation inpatients. J Geriatr Psychiatry Neurol 2004;17:68-72. PMID 15157346
104: Kawada R, Yoshizumi M, Hirao K, et al. Brain volume and dysexecutive behavior in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1255-60. PMID 19625009
105: Kim MS, Kim JJ, Kwon JS. Frontal P300 decrement and executive dysfunction in adolescents with conduct problems. Child Psychiatry Hum Dev 2001;32:93-106. PMID 11758881
106: Kramer JH, Jurik J, Sha SJ, et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol 2003;16:211-8. PMID 14665820
107: Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217-20. PMID 11796772
108: Laiacona M, DeSantis A, Barbarotto R, et al. Neuropsychological follow-up of patients operated for aneurysms of anterior communicating artery. Cortex 1989;25:261-73. PMID 2758852
109: Lambek R, Tannock R, Dalsgaard S, Trillingsgaard A, Damm D, Thomsen PH. Executive dysfunction in school-age children with ADHD. J Atten Disord 2011;15:646-55. PMID 20858784
110: Lee SS, Wood JM, Black AA. Impact of glaucoma on executive function and visual search. Ophthalmic Physiol Opt 2020;40:333-42. PMID 32189400
111: Lezak MD. Neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1983.
112: Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological assessment. 4th ed. New York: Oxford University Press, 2004.
113: Libon DJ, Xie SX, Eppig J, et al. The heterogeneity of mild cognitive impairment: a neuropsychological analysis. J Int Neuropsychol Soc 2010;16:84-93. PMID 19887015
114: Lin CC, Kao SC, Chueh TY, Hung TM. The effects of chronic exercise interventions on executive function in healthy older adults and optimal training characteristics: a systematic review based on randomized controlled trials. Psychol Sport Exerc 2025;80:102925. PMID 40578653
115: Lin H, Chan RC, Zheng L Yang T, Wang Y. Executive functioning in healthy elderly Chinese people. Arch Clin Neuropsychol 2007;22:501-11. PMID 17336035
116: Linek V, Sonka K, Bauer J. Dysexecutive syndrome following anterior thalamic ischemia in the dominant hemisphere. J Neurol Sci 2005;229-30:117-20. PMID 15760629
117: Lloyd D. Virtual lesions and the not so-modular brain. J Intern Neuropsychol Soc 2000;6:627-35. PMID 10932482
118: Logan G. Executive control of thought and action: in search of the wild homunculus. Curr Dir Psychol Sci 2003;12:45-52.
119: Luria AR. Frontal lobe syndromes. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Vol 2. Amsterdam: North Holland, 1969:725-57.
120: Luria AR. Higher cortical functions in man. New York: Consultants Bureau, 1980.
121: Madoz-Gurpide A, Blasco-Fontecilla H, Baca-García E, Ochoa-Mangado E. Executive dysfunction in chronic cocaine users: an exploratory study. Drug Alcohol Depend 2011;117:55-8. PMID 21277707
122: Manchester D, Priestley N, Jackson H. The assessment of executive functions: coming out of the office. Brain Inj 2004;18:1067-81. PMID 15545205
123: Manes F, Sahakian B, Clark L, et al. Decision-making processes following damage to the prefrontal cortex. Brain 2002;125:624-39. PMID 11872618
124: Mantyla T, Carelli MG, Forman H. Time monitoring and executive functioning in children and adults. J Exp Child Psychol 2007;96:1-19. PMID 17030038
125: Martinez-Horta S, Pagonabarraga J, Fernández de Bobadilla R, García-Sanchez C, Kulisevsky J. Apathy in Parkinson's disease: more than just executive dysfunction. J Int Neuropsychol Soc 2013;21:571-82. PMID 23425620
126: Martyr A, Clare L. Executive function and activities of daily living in Alzheimer's disease: a correlational meta-analysis. Dement Geriatr Cogn Disord 2012;33:189-203. PMID 22572810
127: Mateer C. Executive function disorders: rehabilitation challenges and strategies. Semin Clin Neuropsychiatry 1999;4:50-9. PMID 10229793
128: McAlister C, Schmitter-Edgecombe M. Naturalistic assessment of executive function and everyday multitasking in healthy older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2013;20:735-56. PMID 23557096
129: McGuire JT, Botvinick MM. Prefrontal cortex, cognitive control, and the registration of decision costs. Proc Natl Acad Sci U S A 2010;107:7922-6. PMID 20385798
130: McPherson S, Fairbanks L, Tiken S, Cummings JL, Back-Madruga C. Apathy and executive function in Alzheimer's disease. J Int Neuropsychol Soc 2002;8:373-81. PMID 11939696
131: Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsych Clin Neurosci 1994;16:358-70. PMID 7841807
132: Meijers J, Harte JM, Meynen G, Cuijpers P. Differences in executive functioning between violent and non-violent offenders. Psychol Med 2017;47:1784-93. PMID 28173890
133: Mesulam M. Frontal cortex and behavior. Ann Neurol 1986;19:320-5. PMID 3707083
134: Millar D, Griffiths P, Zermansky AJ, Burn DJ. Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy. Mov Disord 2006;21:199-207. PMID 16200534
135: Minghui Q, Wang Y, Chen B, et al. The effects of rTMS and tDCS on repetitive/stereotypical behaviors, cognitive/executive functions in intellectually capable children and young adults with autism spectrum disorder: a systematic review and meta-analysis of randomized controlled trials. Res Dev Disabil 2025;164:105076. PMID 40618530
136: Mitchell RL, Phillips LH. The psychological, neurochemical and functional neuroanatomical mediators of the effects of positive and negative mood on executive functions. Neuropsychologia 2007;45:617-29. PMID 16962146
137: Miyake A, Friedman N, Emerson M, Witzki A, Howerter A. The unity and diversity of executive functions and their contributions to complex ‘‘Frontal Lobe” tasks: A latent variable analysis. Cogn Psychol 2000;41:49-100. PMID 10945922
138: Mok VC, Wong A, Lam WW, et al. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry 2004;75:560-6. PMID 15026497
139: Moorhouse P, Song X, Rockwood K, et al. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study. J Neurol Sci 2010;288:142-6. PMID 19840883
140: Muller SV, Harth S, Hildebrandt H, Munte TF. Evidence based treatment of executive dysfunction. Fortschr Neurol Psychiatry 2006;74:10-8. PMID 16429331
141: Myers JS, Grigsby J, Teel CS, Kramer AM. Nurses' assessment of rehabilitation potential and prediction of functional status at discharge from inpatient rehabilitation. Int J Rehabil Res 2009;32:264-6. PMID 19318974
142: Nagata T, Shinagawa S, Ochiai Y, et al. Association between executive dysfunction and hippocampal volume in Alzheimer's disease. Int Psychogeriatr 2010;25:1-8. PMID 21106135
143: Nilsson JP, Soderstrom M, Karlsson AU, et al. Less effective executive functioning after one night's sleep deprivation. J Sleep Res 2005;14:1-6. PMID 15743327
144: Oppenheim H. Zur Pathologie der Grosshirngeschwülste. [In German]. Arch Psychiatrie Nervenkrankh 1890;21:560-87,705-45.
145: Oppenheim H. Zur Pathologie der Grosshirngeschwülste. [In German]. Arch Psychiatrie Nervenkrankh 1891;22:27-72.
146: Opwonya J, Ku B, Lee KH, Kim JI, Kim JU. Eye movement changes as an indicator of mild cognitive impairment. Front Neurosci 2022;17:1171417. PMID 37397453
147: Ortelli P, Ferrazzoli D, Sebastianelli L, et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: insights into a challenging symptom. J Neurol Sci 2021;420:117271. PMID 33359928
148: Oscar-Berman M. Function and dysfunction of prefrontal brain circuitry in alcoholic Korsakoff's syndrome. Neuropsychol Rev 2012;22;154-69. PMID 22538385
149: Ossenkoppele R, Pijnenburg YA, Perry DC, et al. The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain 2015:138:2732-49. PMID 26141491
150: O'Sullivan M, Barrick TR, Morris RG, Clark CA, Markus HS. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 2005;65:1584-90. PMID 16301485
151: Owen AM, James M, Leigh P. Frontostriatal cognitive deficits at different stages of Parkinson's disease. Brain 1992;115:1727-57. PMID 1486458
152: Pa J, Boxer A, Chao LL, et al. Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol 2009;65:414-23. PMID 19399879
153: Parent A, Cote P, Lavoie B. Chemical anatomy of primate basal ganglia. Progress Neurobiol 1995;46:131-97. PMID 7568912
154: Pasquier F, Grymonprez L, Lebert F, Van Der Linden M. Memory impairment differs in frontotemporal dementia and Alzheimer's disease. Neurocase 2001;7:161-71. PMID 11320163
155: Peric S, Mandic-Stojmenovic G, Stefanova E, et al. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2. J Neurol 2015;262:142-8. PMID 25346064
156: Petersen RC, Smith GE , Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8. PMID 10190820
157: Poncet F, Swaine B, Migeot H, Lamoureux J, Picq C, Pradat P. Effectiveness of a multidisciplinary rehabilitation program for persons with acquired brain injury and executive dysfunction. Disabil Rehabil 2018;40:1569-83. PMID 28374649
158: Rabinovitz B, Jaywant A, Fridman CB. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID-19 pandemic. Clin Neuropsychol 2020;34:1453-79. PMID 32901580
159: Ratiu P, Talos IF, Haker S, Lieberman D, Everett P. The tale of Phineas Gage, digitally remastered. J Neurotrauma 2004;21:637-43. PMID 15165371
160: Rajtar-Zembaty A, Sałakowski A, Rajtar-Zembaty J, Starowicz-Filip A. Executive dysfunction in late-life depression. Psychiatr Pol 2017;51:705-18. PMID 28987059
161: Roca M, Manes F, Chade A, et al. The relationship between executive functions and fluid intelligence in Parkinson's disease. Psychol Med 2012;22:1-8. PMID 22440401
162: Rodriguez-Aranda C, Sundet K. The frontal hypothesis of cognitive aging: factor structure and age effects on four frontal tests among healthy individuals. J Genet Psychol 2006;167:269-87. PMID 17278416
163: Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos JM, Lyketsos CG. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry 2011;26:364-72. PMID 20845402
164: Ross ED, Stewart RM. Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology 1981;31:1435-9. PMID 6118841
165: Ross SR, Benning SD, Adams Z. Symptoms of executive dysfunction are endemic to secondary psychopathy: an examination in criminal offenders and noninstitutionalized young adults. J Personal Disord 2007;21:384-99. PMID 17685835
166: Runk A, Jia Y, Liu A, Chang CH, Ganguli M, Snitz BE. Associations between visual acuity and cognitive decline in older adulthood: a 9-year longitudinal study. J Int Neuropsychol Soc 2023;29:1-11. PMID 36630994
167: Samat NA, Abdul Murad NA, Mohamad K, Abdul Razak MR, Mohamed Ibrahim N. Apolipoprotein Eε4: a biomarker for executive dysfunction among Parkinson's disease patients with mild cognitive impairment. Front Neurosci 2017;11:712. PMID 29326545
168: Saxena S, Bota R, Brody A. Brain-behavior relationships in obsessive compulsive disorder research program. Semin Clin Neuropsychiatry 2001;6:86-101. PMID 11296309
169: Schoemaker K, Bunte T, Weibe SA, Espy KA, Dekovic M, Matthys W. Executive function deficits in preschool children with ADHD and DBD. J Child Psychol Psychiatry 2012;53:111-9. PMID 22022931
170: Schulz D, Kopp B, Kunkel A, Faiss JH. Cognition in the early stage of multiple sclerosis. J Neurol 2006;253:1002-10. PMID 16609812
171: Scully PJ, Coakley G, Kinsella A. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med 1997;27:1303-10. PMID 9403902
172: Segaux L, Oubaya N, Leissing-Desprez C, et al. More than a third of middle-aged adults (50-65) have understated executive dysfunction. Aging Ment Health 2023;27(4):708-14. PMID 35243938
173: Seichepine DR, Stamm JM, Daneshvar DH, et al. Profile of self-reported problems with executive functioning in college and professional football players. J Neurotrauma 2013;30:1299-304. PMID 23421745
174: Seidman LJ, Biederman J, Monuteaux MC, Valera E, Doyle AE, Faraone SV. Impact of gender and age on executive functioning: do girls and boys with and without attention deficit hyperactivity disorder differ neuropsychologically in preteen and teenage years. Dev Neuropsychol 2005;27:79-105. PMID 15737943
175: Shorland G, Genty E, Guéry JP, Zuberbühler K. Investigating self-recognition in bonobos: mirror exposure reduces looking time to self but not unfamiliar conspecifics. PeerJ 2020;8:e9685. PMID 32923178
176: Simblett SK, Ring H, Bateman A. The Dysexecutive Questionnaire Revised (DEX-R): An extended measure of everyday dysexecutive problems after acquired brain injury. Neuropsychol Rehabil 2017;27:1124-41. PMID 26784858
177: Sjobeck M, Elfgren C, Larsson EM, et al. Alzheimer's disease (AD) and executive dysfunction. A case-control study on the significance of frontal white matter changes detected by diffusion tensor imaging (DTI). Arch Gerontol Geriatr 2010;50:260-6. PMID 19419776
178: Skidmore E, Eskes G, Brodtmann A. Executive function poststroke: concepts, recovery and interventions [review]. Stroke 2023;54(1):20-9. PMID 36542071
179: Smith DG, Jones PS, Bullmore ET, Robbins TW, Ersche KD. Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings. Transl Psychiatry 2013;3:e257. PMID 23673468
180: Snowden JS, Neary D, Mann DM. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. New York: Churchill Livingstone, 1996.
181: Spikman JM, Boelen DH, Lamberts KF, Brouwer WH, Fasotti L. Effects of a multifaceted treatment program for executive dysfunction after acquired brain injury on indications of executive functioning in daily life. J Int Neuropsychol Soc 2010;16:118-29. PMID 19900348
182: Staffaroni AM, Clark AL, Taylor JC, et al. Reliability and validity of smartphone cognitive testing for frontotemporal lobar degeneration. JAMA Netw Open 2024;7:e244266. PMID 38558141
183: Stokholm J,Vogel A, Gade A, Waldemar G. Heterogeneity in executive impairment in patients with very mild Alzheimer's disease. Dement Geriatr Cogn Disord 2006;22:54-9. PMID 16682794
184: Stout JC, Ready RE, Grace J, Malloy PF, Paulsen JS. Factor analysis of the frontal systems behavior scale (FrSBe). Assessment 2003;10:79-85. PMID 12675387
185: Stuss DT, Knight RT. Principles of frontal lobe function. Oxford: Oxford University Press, 2002.
186: Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 2002;53:401-33. PMID 11752491
187: Suchy Y, Derbidge C, Cope C. Behavioral Dyscontrol Scale-electronic version: first examination of reliability, validity, and incremental utility. Clin Neuropsychol 2005;19:4-26. PMID 15814475
188: Suchy Y, Gereau Mora M, Brothers SL, DesRuisseaux LA. Six elements test vs D-KEFS: what does "Ecological Validity" tell us? J Int Neuropsychol Soc 2024;30:350-9. PMID 38465734
189: Super H, Spekreijse H, Lamme VA. A neural correlate of working memory in the monkey primary visual cortex. Science 2001;293:120-4. PMID 11441187
190: Szesko PR, Robinson D, Ma J, Aluv J, Bilder R. Obsessive compulsive disorder: physiological aspects. Arch Gen Psychiatry 1999;56:913-23.
191: Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. PMID 34582441
192: Testa R, Bennett P, Ponsford J. Factor analysis of nineteen executive function tests in a healthy adult population. Arch Clin Neuropsychol 2012;27:213-24. PMID 22314610
193: Toba MN, Malkinson TS, Howells H, Mackie MA, Spagna A. Same, same but different? A multi-method review of the processes underlying executive control. Neuropsychol Rev 2024;34:418-54. PMID 36967445
194: Tonnaer F, Cima M, Arntz A. Executive (dys)functioning and impulsivity as possible vulnerability factors for aggression in forensic patients. J Nerv Ment Dis 2016;204:280-6. PMID 26894312
195: Torralva T, Roca M, Gleichgerrcht E, Bekinschtein T, Manes F. A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia. Brain 2009;132:1299-309. PMID 19336463
196: Tsoi T, Baillon S, Lindesay J. Early frontal executive impairment as a predictor of subsequent behavior disturbance in dementia. Am J Geriatr Psychiatry 2008;16:102-8. PMID 18239195
197: Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-53. PMID 15277616
198: van Aken L, Kessels RP, Wingbermühle E, van der Veld WM, Egger JI. Fluid intelligence and executive functioning more alike than different? Acta Neuropsychiatr 2016;28:31-7. PMID 26281913
199: van Rijn S, Swaab H. Executive dysfunction and the relation with behavioral problems in children with 47,XXY and 47,XXX. Genes Brain Behav 2015;14:200-8. PMID 25684214
200: Veldsman M, Werden E, Egorova N, Khlif MS, Brodtmann A. Microstructural degeneration and cerebrovascular risk burden underlying executive dysfunction after stroke. Sci Rep 2020;10:17911. PMID 33087782
201: Vincent C. Neurochirurgische Betrachtungen über die Funktionen des Frontallappens. [In German]. Med Wochenschur 1936;62:41-5.
202: Walker AE. The primate thalamus. Chicago: University of Chicago Press, 1938.
203: Wall KJ, Cumming TB, Copland DA. Determining the association between language and cognitive tests in poststroke aphasia. Front Neurol 2017;8:149. PMID 28529495
204: Wang Z, Liu Y, Li C, Qin K, Yu X, Xie A. Music-based intervention as a new therapeutic treatment for executive dysfunction in Parkinson's disease. Neuroscience 2025;580:306-14. PMID 40588094
205: Wiebe DJ, Berg CA, Munion AK, et al. Executive functioning, daily self-regulation, and diabetes management while transitioning into emerging adulthood. Ann Behav Med 2023;57:676-86. PMID 37163736
206: Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural Assessment of the Dysexecutive Syndrome (BADS). San Antonio: Harcourt Assessment, Inc, 1996.
207: Wolinsky FD, Vander Weg MW, Howren MB, Jones MP, Dotson MM. A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults. PLoS One 2013;8:e61624. PMID 23650501
208: Woods AJ, Mark VW, Pitts AC, Mennemeier M. Pervasive cognitive impairment in acute rehabilitation inpatients without brain injury. PM R 2011;3:426-32. PMID 21570030
209: Yochim BP, Mueller AE, Segal DL. Late life anxiety is associated with decreased memory and executive functioning in community dwelling older adults. J Anxiety Disord 2013;27:567-75. PMID 23298889
210: Young CB, Cholerton B, Smith AM, et al. The Parkinson's disease composite of executive functioning: a measure for detecting cognitive decline in clinical trials. Neurology 2024;103:e209609. PMID 38870440
211: Zartman AL, Hilsabeck RC, Guarnaccia CA, Houtz A. The Pillbox Test: an ecological measure of executive functioning and estimate of medication management abilities. Arch Clin Neuropsychol 2013;28:307-19. PMID 23502807
212: Zgaljardic DJ, Borod JC, Foldi NS, Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003;16:193-210. PMID 14665819

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Victor W Mark MD

Dr. Mark of the University of Alabama at Birmingham has no relevant financial relationships to disclose.
See Profile

Former Authors

Cheri Surloff PhD PsyD
Alfredo Ardila PhD

Patient Profile

Age range of presentation: 13 to 65+ years
Sex preponderance: male=female
Heredity: none
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Executive dysfunction

Associated Disorders

Human immunodeficiency virus
Huntington disease
Multiple sclerosis
Multisystem atrophy
Parkinson disease
- Progressive supranuclear palsy
- Subcortical lacunes
- Subcortical vascular dementia
- Wilson disease

Differential Diagnosis

normal aging
dementia
Pick disease
traumatic brain injury
Alzheimer disease
- mild cognitive impairment
- memory dysfunctions
- depression
- affective disorders

Also Relevant

Alzheimer disease
Attention deficit hyperactivity disorder
Automatic-voluntary dissociation
Frontotemporal dementia
HIV-associated dementia
- Huntington disease
- Multiple sclerosis: presentation and course
- Multiple sclerosis: neurobehavioral aspects
- Parkinson disease
- Progressive supranuclear palsy
- Progressive supranuclear palsy: cognitive and behavioral changes
- Subcortical vascular cognitive impairment
- Theory of Mind
- Wilson disease

Clinical Categories

Web References

Guidelines

AAN: Dementia

Clinical Trials

NIH: Executive Dysfunction

Executive dysfunction …

Executive dysfunction

Cite this article

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Upadacitinib

Cryptococcal meningitis

GM2 gangliosidoses

Developmental delay in children: evaluation and management

Levacetylleucine

Dextromethorphan hydrobromide and quinidine sulfate

DNA- and RNA-directed gene therapies

Whipple disease

Executive dysfunction

Cite this article

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Upadacitinib

Cryptococcal meningitis

GM2 gangliosidoses

Developmental delay in children: evaluation and management

Levacetylleucine

Dextromethorphan hydrobromide and quinidine sulfate

DNA- and RNA-directed gene therapies

Whipple disease

This is an article preview.
Start a Free Account
to access the full version.